← Back to Search

Lifestyle Management Program for Obesity(CHAMPS Trial)

Led By Karen Johnson, MD
Research Sponsored by University of Tennessee
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
are overweight or obese (BMI ≥ 25 kg/m2)
Must not have
Screening 3 weeks
Treatment Varies
Follow Up12 months
Awards & highlights
No Placebo-Only Group

CHAMPS Trial Summary

This trial will test whether a weight loss intervention delivered through health IT tools can help people lose more weight than a diabetes support and education intervention.

Eligible Conditions
  • Overweight and Obesity
  • Weight Loss
  • Health Behaviors

CHAMPS Trial Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You have a body mass index (BMI) greater than or equal to 25, which means you are overweight or obese.

CHAMPS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Relative percentage change in weight
Secondary outcome measures
Relationship of social determinants of health (BRFSS) with weight change over time
Relationship of social determinants of health (screening tool) with weight change over time
Relationship of social determinants of health (z codes) with weight change over time

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

CHAMPS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Active Intervention GroupExperimental Treatment1 Intervention
Look AHEAD Intervention program adapted for delivery via Health IT modified for cultural and social norms applicable to under-served population groups
Group II: Comparison GroupActive Control1 Intervention
Look AHEAD DSE (Diabetes Support and Education) Comparison Group intervention adapted to be delivered via the EHR patient portal with telephonic support

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,490 Previous Clinical Trials
41,266,465 Total Patients Enrolled
45 Trials studying Obesity
21,989 Patients Enrolled for Obesity
Regional One HealthOTHER
4 Previous Clinical Trials
743 Total Patients Enrolled
University of TennesseeLead Sponsor
188 Previous Clinical Trials
141,827 Total Patients Enrolled
19 Trials studying Obesity
3,433 Patients Enrolled for Obesity

Media Library

Active Intervention Group Clinical Trial Eligibility Overview. Trial Name: NCT05410353 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this research initiative still open to participants?

"Confirmed, this study is not enrolling patients. The trial was initially advertised on January 1st 2023 and its status last changed on June 8th 2022. Nevertheless, there are currently 1293 other clinical trials with open enrollment requirements."

Answered by AI

Who else is applying?

What state do they live in?
What portion of applicants met pre-screening criteria?
Met criteria
~167 spots leftby Jun 2027